LED Therapy for Third Molar Surgery

Launched by HUASHAN HOSPITAL · Oct 10, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called LED therapy for patients undergoing surgery to remove wisdom teeth, also known as third molars. The goal is to see if this light-based therapy can help improve healing and reduce discomfort after the surgery. The study will include healthy Asian adults aged 20 to 55 who need to have their wisdom teeth removed due to issues like cavities or orthodontic needs.

To participate in this trial, individuals must be generally healthy and not have certain medical conditions, such as diabetes or heart disease. They also should not be pregnant or breastfeeding, and they should not have taken specific medications within two weeks prior to the surgery. If eligible, participants can expect to receive the LED therapy during their procedure and will be monitored for their recovery. As this trial is not yet recruiting, it’s a great opportunity for those who qualify to contribute to understanding new ways to improve dental surgery outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Healthy Asians;
• • 2. 20-55 years old;
• • 3. Having mandibular third molars that are inappropriately erupted and need to be extracted due to caries, orthodontic reasons and/or periodontal disease;
• Exclusion Criteria:
• • 1. Underlying diseases: diabetes, cardiovascular disease, coagulation disorder, osteoporosis, hypertension, neurological disease, psychological disorder, tumor, systemic infection or cyst at the extraction site;
• • 2. Women who are preparing for pregnancy, pregnant or breastfeeding;
• • 3. Medication history: use of analgesics, anti-inflammatory drugs and/or antibacterial drugs 2 weeks before tooth extraction, need for systemic medication other than acetaminophen after surgery, allergy to acetaminophen, use of anticoagulants, bisphosphonates;
• • 4. Bad habits, such as addicted to smoking, drinking, etc.;
• • 5. Volunteers who have recently participated in other clinical trials;